Green Cross Holdings Corporation (005257.KS)
KRW 23150.0
(1.09%)
KRW 23150.0
(1.09%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 34.43 Billion KRW | -57.85% |
| 2022 | 81.26 Billion KRW | -53.93% |
| 2021 | 176.4 Billion KRW | 391.42% |
| 2020 | 35.89 Billion KRW | -10.82% |
| 2019 | 40.25 Billion KRW | -19.73% |
| 2018 | 50.15 Billion KRW | -44.46% |
| 2017 | 90.29 Billion KRW | 15.1% |
| 2016 | 78.45 Billion KRW | -14.43% |
| 2015 | 91.68 Billion KRW | -5.45% |
| 2014 | 96.96 Billion KRW | 23.04% |
| 2013 | 78.8 Billion KRW | 5.99% |
| 2012 | 74.35 Billion KRW | -15.83% |
| 2011 | 88.33 Billion KRW | -39.34% |
| 2010 | 145.62 Billion KRW | 21.98% |
| 2009 | 119.38 Billion KRW | 75.75% |
| 2008 | 67.93 Billion KRW | 16.23% |
| 2007 | 58.44 Billion KRW | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 17.6 Billion KRW | 217.21% |
| 2024 Q1 | -15.01 Billion KRW | -70.77% |
| 2024 Q3 | 39.6 Billion KRW | 125.0% |
| 2023 FY | 34.25 Billion KRW | -57.85% |
| 2023 Q4 | -8.79 Billion KRW | -126.85% |
| 2023 Q3 | 32.75 Billion KRW | 421.98% |
| 2023 Q2 | 6.27 Billion KRW | 146.18% |
| 2023 Q1 | -13.58 Billion KRW | -32.58% |
| 2022 Q4 | -10.24 Billion KRW | -121.02% |
| 2022 Q1 | 41.84 Billion KRW | 400.49% |
| 2022 Q2 | 17.76 Billion KRW | -57.54% |
| 2022 FY | 81.26 Billion KRW | -53.93% |
| 2022 Q3 | 48.75 Billion KRW | 174.37% |
| 2021 Q3 | 71.5 Billion KRW | 543.75% |
| 2021 Q4 | -13.92 Billion KRW | -119.48% |
| 2021 Q1 | 4.97 Billion KRW | 122.36% |
| 2021 FY | 176.4 Billion KRW | 391.42% |
| 2021 Q2 | 11.1 Billion KRW | 123.47% |
| 2020 Q3 | 50.74 Billion KRW | 224.77% |
| 2020 Q1 | 6.12 Billion KRW | 135.35% |
| 2020 Q4 | -22.23 Billion KRW | -143.82% |
| 2020 FY | 35.89 Billion KRW | -10.82% |
| 2020 Q2 | 15.62 Billion KRW | 155.23% |
| 2019 FY | 40.25 Billion KRW | -19.73% |
| 2019 Q4 | -17.31 Billion KRW | -147.37% |
| 2019 Q2 | 19.63 Billion KRW | 1325.31% |
| 2019 Q3 | 36.55 Billion KRW | 86.18% |
| 2019 Q1 | 1.37 Billion KRW | 124.52% |
| 2018 Q3 | 27.99 Billion KRW | 110.31% |
| 2018 FY | 50.15 Billion KRW | -44.46% |
| 2018 Q4 | -5.61 Billion KRW | -120.07% |
| 2018 Q2 | 13.31 Billion KRW | -7.95% |
| 2018 Q1 | 14.46 Billion KRW | 12324.7% |
| 2017 FY | 90.29 Billion KRW | 15.1% |
| 2017 Q4 | 116.39 Million KRW | -99.72% |
| 2017 Q3 | 41.96 Billion KRW | 21.53% |
| 2017 Q2 | 34.53 Billion KRW | 152.43% |
| 2017 Q1 | 13.68 Billion KRW | 52.73% |
| 2016 FY | 78.45 Billion KRW | -14.43% |
| 2016 Q3 | 34.58 Billion KRW | 43.87% |
| 2016 Q4 | 8.95 Billion KRW | -74.1% |
| 2016 Q2 | 24.03 Billion KRW | 121.19% |
| 2016 Q1 | 10.86 Billion KRW | 1800.76% |
| 2015 FY | 91.68 Billion KRW | -5.45% |
| 2015 Q4 | 571.79 Million KRW | -98.81% |
| 2015 Q1 | 12.69 Billion KRW | 5.43% |
| 2015 Q3 | 48.18 Billion KRW | 59.42% |
| 2015 Q2 | 30.22 Billion KRW | 138.06% |
| 2014 Q4 | 12.04 Billion KRW | -76.66% |
| 2014 Q3 | 51.58 Billion KRW | 165.14% |
| 2014 Q1 | 13.87 Billion KRW | 153.28% |
| 2014 Q2 | 19.45 Billion KRW | 40.21% |
| 2014 FY | 96.96 Billion KRW | 23.04% |
| 2013 Q3 | 44.41 Billion KRW | 160.24% |
| 2013 Q1 | 11.84 Billion KRW | 271.03% |
| 2013 Q4 | 5.47 Billion KRW | -87.66% |
| 2013 FY | 78.8 Billion KRW | 5.99% |
| 2013 Q2 | 17.06 Billion KRW | 44.14% |
| 2012 Q1 | 20.84 Billion KRW | 93.36% |
| 2012 Q4 | -6.92 Billion KRW | -115.67% |
| 2012 Q3 | 44.19 Billion KRW | 172.26% |
| 2012 Q2 | 16.23 Billion KRW | -22.13% |
| 2012 FY | 74.35 Billion KRW | -15.83% |
| 2011 Q4 | 10.78 Billion KRW | -76.65% |
| 2011 FY | 88.33 Billion KRW | -39.34% |
| 2011 Q3 | 46.18 Billion KRW | 213.74% |
| 2011 Q2 | 14.71 Billion KRW | -12.89% |
| 2011 Q1 | 16.89 Billion KRW | 0.0% |
| 2010 Q1 | 88.41 Billion KRW | 35.04% |
| 2010 Q3 | 34.37 Billion KRW | 64.2% |
| 2010 Q4 | - KRW | -100.0% |
| 2010 FY | 145.62 Billion KRW | 21.98% |
| 2010 Q2 | 20.93 Billion KRW | -76.32% |
| 2009 Q2 | 19.96 Billion KRW | 55.14% |
| 2009 Q1 | 12.87 Billion KRW | -20.38% |
| 2009 Q3 | 20.79 Billion KRW | 4.15% |
| 2009 Q4 | 65.47 Billion KRW | 214.88% |
| 2009 FY | 119.38 Billion KRW | 75.75% |
| 2008 Q4 | 16.16 Billion KRW | -20.18% |
| 2008 FY | 67.93 Billion KRW | 16.23% |
| 2008 Q3 | 20.25 Billion KRW | 4.29% |
| 2008 Q2 | 19.41 Billion KRW | 64.57% |
| 2008 Q1 | 11.79 Billion KRW | 23.82% |
| 2007 Q1 | 13.05 Billion KRW | 0.0% |
| 2007 Q3 | 19.11 Billion KRW | 16.11% |
| 2007 Q4 | 9.52 Billion KRW | -50.15% |
| 2007 FY | 58.44 Billion KRW | 0.0% |
| 2007 Q2 | 16.46 Billion KRW | 26.14% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| ORIENT BIO Inc. | 1.45 Billion KRW | -2270.315% |
| Green Cross Holdings Corporation | -16.43 Billion KRW | 309.492% |
| Pharmicell Co., Ltd. | 950.99 Million KRW | -3521.062% |
| Green Cross Corporation | 34.43 Billion KRW | 0.0% |
| GeneOne Life Science, Inc. | -48.36 Billion KRW | 171.196% |
| Celltrion, Inc. | 651.43 Billion KRW | 94.714% |
| Samsung Biologics Co.,Ltd. | 1155.98 Billion KRW | 97.021% |
| SK bioscience Co.,Ltd. | -4.73 Billion KRW | 827.885% |
| SK Biopharmaceuticals Co., Ltd. | -37.52 Billion KRW | 191.775% |
| Prestige BioPharma Limited | -62.78 Billion KRW | 154.85% |